Table 2.
Model | LP(a) as a nominal variablea | LP(a) as a continuous variableb | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | |
Crude model | 1.819 | 1.241–2.666 | 0.002 | 1.255 | 1.094–1.439 | 0.001 |
Model 1 | 1.850 | 1.262–2.713 | 0.002 | 1.264 | 1.100–1.453 | <0.001 |
Model 2 | 1.937 | 1.313–2.856 | <0.001 | 1.280 | 1.115–1.470 | <0.001 |
Model 3 | 2.068 | 1.366–3132 | <0.001 | 1.285 | 1.112–1.484 | <0.001 |
Model 1: adjusted for age, sex and type of ACS.
Model 2: adjusted for variables in model 1 and smoking, diabetes and hypertension.
Model 3: adjusted for variables in model 2 and LDL-C, serum creatinine and PCI.
ACS, acute coronary syndrome; CI, confidence interval; HR, hazard ratio; Lp(a), lipoprotein(a); PCI, percutaneous coronary intervention.
The HR was examined regarding low-Lp(a) group as reference.
The HR was examined by per 1-SD increase of Lp(a).